Table 1.
Group | Body Wt, g | Liver Wt, g | Liver Wt/Body Wt, % | Serum ALT, IU/l | Serum TGs, mg/dl | Liver TGs, mg/mg protein |
---|---|---|---|---|---|---|
WT Con | 29.3 ± 1.0 | 1.30 ± 0.08 | 4.5 ± 0.20 | 34 ± 2.5 | 86 ± 6.4 | 1.5 ± 0.38 |
WT EtOH | 32.2 ± 0.8a | 1.49 ± 0.06 | 4.6 ± 0.14 | 50 ± 6.8a | 142 ± 15a | 3.5 ± 0.40a |
CypD−/− Con | 29.0 ± 2.0 | 1.45 ± 0.10 | 5.0 ± 0.13 | 40 ± 6.0 | 78 ± 16 | 1.7 ± 0.20 |
CypD−/− EtOH | 31.5 ± 1.2 | 1.80 ± 0.13b,c | 5.7 ± 0.30b,c | 65 ± 10 | 187 ± 26b,c | 5.3 ± 0.70b,c |
2-Factor ANOVA (P values) | ||||||
Diet | 0.028 | 0.028 | 0.103 | 0.007 | <0.001 | <0.001 |
Genotype | 0.383 | 0.054 | 0.001 | 0.850 | 0.168 | 0.109 |
Interaction (diet × genotype) | 0.506 | 0.369 | 0.101 | 0.672 | 0.088 | 0.113 |
Values are means ± SE; n = 6–8 mice per group.
WT, wild-type; CypD−/−, cyclophilin D-null; Con, control diet; EtOH, ethanol-containing diet; ALT, alanine aminotransferase; TGs, triglycerides.
Results from post hoc statistical analyses P < 0.05 vs. WT Con;
P < 0.05 vs. CypD−/− Con;
P < 0.05 vs. WT EtOH.